Back to Search Start Over

Advances and clinical challenges of mesenchymal stem cell therapy.

Authors :
Ruiyan Mei
Zhuo Wan
Cheng Yang
Xiangjing Shen
Ronglin Wang
Haihua Zhang
Rui Yang
Junqiang Li
Yang Song
Haichuan Su
Source :
Frontiers in Immunology; 2024, p1-14, 14p
Publication Year :
2024

Abstract

In recent years, cell therapy has provided desirable properties for promising new drugs. Mesenchymal stem cells are promising candidates for developing genetic engineering and drug delivery strategies due to their inherent properties, including immune regulation, homing ability and tumor tropism. The therapeutic potential of mesenchymal stem cells is being investigated for cancer therapy, inflammatory and fibrotic diseases, among others. Mesenchymal stemcells are attractive cellular carriers for synthetic nanoparticles for drug delivery due to their inherent homing ability. In this review, we comprehensively discuss the various genetic and nongenetic strategies of mesenchymal stem cells and their derivatives in drug delivery, tumor therapy, immune regulation, tissue regeneration and other fields. In addition, we discuss the current limitations of stem cell therapy and the challenges in clinical translation, aiming to identify important development areas and potential future directions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
178870300
Full Text :
https://doi.org/10.3389/fimmu.2024.1421854